WebDec 23, 2024 · Presented results in conjunction with EntheogeniX Biosciences on psychedelics for medicine at Society for Neuroscience (SfN) 2024 conference. Licensing deals with large pharma leveraging Ligand Express; collaborations with large pharma companies leveraging DDD and Ligand Express; equity positions in small pharma and … WebApr 24, 2024 · Born out of the desire to create psychedelic compounds more scalable than psilocybin, biotech startup EntheogeniX wants to make new, short-acting drugs that are “pharmacologically cleaner” than magic …
Srinivas G. Rao - Biography
WebFeb 16, 2024 · EntheogeniX is leveraging Cyclica’s unique AI-enabled computational biophysics platform to generate de novo chemical entities — selecting for across a … manusya chestpiece of healing
Cyclica Raises CAD$23 Million in a Series B Financing to Create …
WebJun 24, 2024 · Srinivas Rao, MD, PhD, CEO of EntheogeniX Biosciences and CSO of ATAI Life Sciences had this to say: “Cyclica’s computational platform shaved many months off of our timeline, and allowed us to achieve our objective of generating completely novel, synthetically tractable lead-like compounds. The flexibility, speed, and passion of the … Web“One of atai’s drug discovery engines, Entheogenix Biosciences, uses artificial intelligence to be able to rapidly design novel molecules by… Beliebt bei Philipp Remsperger. Happy birthday to me! 🎉 As I reflect on the past year, it's clear that it's been full of change and growth. I took bold steps, quitting my… WebEntheogenix Biosciences is a biotech company dedicated to advancing psychedelic research for the development of better medicines for mental health diseases such as … The EntheogeniX Team . Glenn Short, CEO and Board Member. Glenn Short, Ph.D., … Cyclica is teaming up with Berlin-based biotechnology company ATAI Life … EntheogeniX Biosciences. Our Work. Team News Contact. Follow. Twitter LinkedIn ... Entheogenix Biosciences Inc, the Delaware-based company jointly-founded as part … manu surf shop